Identification of the antibiotic determined by the SCP1 plasmid of Streptomyces coelicolor A3(2).
The antibiotic whose biosynthesis is determined by the SCP1 plasmid of Streptomyces coelicolor A3(2) has been characterized as the recently described methylenomycin A (2-methylene-cyclopentan-3-one-4,5-epoxy-4,5-dimethyl-1-carboxylic acid).
D000900:Anti-Bacterial Agents / Q000032:analysis / Q000096:biosynthesis* / Q000494:pharmacology; D001407:Bacillus / Q000187:drug effects; D001409:Bacillus cereus / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D005111:Extrachromosomal Inheritance; D010957:Plasmids; D011513:Proteus mirabilis / Q000187:drug effects; D013045:Species Specificity; D013171:Spores, Bacterial / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects; D013302:Streptomyces / Q000378:metabolism*
D000900:Anti-Bacterial Agents